nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenidol—Bepridil—KCNQ1—type 2 diabetes mellitus	0.016	0.253	CrCbGaD
Diphenidol—Bepridil—CALM1—type 2 diabetes mellitus	0.00761	0.121	CrCbGaD
Diphenidol—Clotrimazole—CYP11A1—type 2 diabetes mellitus	0.00701	0.111	CrCbGaD
Diphenidol—Loperamide—CALM1—type 2 diabetes mellitus	0.00674	0.107	CrCbGaD
Diphenidol—Clotrimazole—ABCC2—type 2 diabetes mellitus	0.00385	0.0611	CrCbGaD
Diphenidol—Benzphetamine—ADRA2A—type 2 diabetes mellitus	0.00281	0.0445	CrCbGaD
Diphenidol—Clotrimazole—CYP2E1—type 2 diabetes mellitus	0.0027	0.0429	CrCbGaD
Diphenidol—Clotrimazole—CYP1A2—type 2 diabetes mellitus	0.00257	0.0408	CrCbGaD
Diphenidol—Darifenacin—CYP3A4—type 2 diabetes mellitus	0.00227	0.0359	CrCbGaD
Diphenidol—Levomethadyl Acetate—CYP3A4—type 2 diabetes mellitus	0.0017	0.027	CrCbGaD
Diphenidol—Clotrimazole—CYP3A4—type 2 diabetes mellitus	0.0017	0.027	CrCbGaD
Diphenidol—Methadone—CYP1A2—type 2 diabetes mellitus	0.00151	0.0239	CrCbGaD
Diphenidol—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	0.00147	0.0233	CrCbGaD
Diphenidol—Fentanyl—CYP3A4—type 2 diabetes mellitus	0.00146	0.0231	CrCbGaD
Diphenidol—Loperamide—CYP3A4—type 2 diabetes mellitus	0.0014	0.0222	CrCbGaD
Diphenidol—Benzphetamine—CYP3A4—type 2 diabetes mellitus	0.00129	0.0205	CrCbGaD
Diphenidol—Methadone—CYP3A4—type 2 diabetes mellitus	0.000998	0.0158	CrCbGaD
Diphenidol—CHRM3—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000294	0.000314	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000293	0.000313	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000292	0.000312	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000292	0.000311	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000291	0.000311	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000291	0.000311	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000291	0.00031	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000291	0.00031	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000291	0.00031	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.00029	0.00031	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.00029	0.000309	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000289	0.000308	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000289	0.000308	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000288	0.000307	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000287	0.000307	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000286	0.000305	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000286	0.000305	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000285	0.000304	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000283	0.000302	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000282	0.000301	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000279	0.000298	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000279	0.000297	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—GCG—type 2 diabetes mellitus	0.000279	0.000297	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000279	0.000297	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000278	0.000296	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000277	0.000295	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000276	0.000294	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000274	0.000292	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.00027	0.000288	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000269	0.000288	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000269	0.000288	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000269	0.000287	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000269	0.000287	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000269	0.000287	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000267	0.000285	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000266	0.000284	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000266	0.000284	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000266	0.000283	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000265	0.000282	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000262	0.00028	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000262	0.00028	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000261	0.000279	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000261	0.000279	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000261	0.000279	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.00026	0.000278	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.00026	0.000278	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000259	0.000276	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000258	0.000275	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000258	0.000275	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000257	0.000274	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000256	0.000273	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000255	0.000273	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000255	0.000273	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000255	0.000272	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000255	0.000272	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000253	0.00027	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000252	0.000269	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000252	0.000269	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000252	0.000269	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000252	0.000268	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000249	0.000266	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000245	0.000262	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000245	0.000261	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000242	0.000258	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.00024	0.000256	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	0.00024	0.000256	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	0.000239	0.000255	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000238	0.000254	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000237	0.000253	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000237	0.000252	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000236	0.000252	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	0.000236	0.000252	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000235	0.00025	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000234	0.000249	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000234	0.000249	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000234	0.000249	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000233	0.000249	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000233	0.000249	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000231	0.000246	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000231	0.000246	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.00023	0.000245	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000229	0.000245	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000229	0.000245	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	0.000229	0.000244	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000228	0.000244	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000227	0.000242	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000226	0.000241	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	0.000223	0.000238	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000219	0.000233	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	0.000219	0.000233	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000218	0.000233	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000216	0.00023	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000215	0.000229	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000215	0.000229	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000214	0.000229	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	0.000214	0.000228	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000214	0.000228	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	0.000213	0.000228	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000212	0.000226	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000212	0.000226	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	0.000208	0.000222	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000205	0.000219	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000203	0.000217	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000203	0.000216	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000201	0.000215	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000201	0.000214	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000201	0.000214	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000199	0.000212	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000199	0.000212	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000199	0.000212	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000198	0.000211	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000198	0.000211	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000198	0.000211	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000197	0.00021	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000197	0.00021	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	0.000197	0.00021	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000196	0.00021	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000196	0.000209	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000196	0.000209	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000195	0.000208	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000195	0.000208	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000194	0.000207	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000194	0.000207	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	0.000193	0.000206	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000192	0.000205	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000192	0.000205	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000191	0.000204	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000191	0.000204	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000191	0.000203	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	0.00019	0.000202	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000189	0.000202	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000189	0.000201	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000188	0.000201	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	0.000187	0.0002	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000187	0.000199	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	0.000184	0.000196	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000183	0.000196	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	0.000183	0.000196	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000183	0.000195	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	0.000181	0.000193	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000181	0.000193	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000179	0.000192	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000179	0.000191	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000177	0.000189	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000172	0.000184	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000171	0.000183	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.00017	0.000181	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000169	0.00018	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000168	0.00018	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000167	0.000178	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	0.000165	0.000176	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	0.000165	0.000176	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	0.000163	0.000174	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	0.00016	0.00017	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000157	0.000168	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000157	0.000168	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000157	0.000167	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000157	0.000167	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000157	0.000167	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—INS—type 2 diabetes mellitus	0.000157	0.000167	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000156	0.000167	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000155	0.000166	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000155	0.000165	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000155	0.000165	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000154	0.000165	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000154	0.000164	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000154	0.000164	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000154	0.000164	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000153	0.000163	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000153	0.000163	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000152	0.000162	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000152	0.000162	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000152	0.000162	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000152	0.000162	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000151	0.000162	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.00015	0.00016	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000145	0.000155	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000144	0.000154	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	0.000143	0.000153	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000143	0.000153	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	0.000137	0.000146	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	0.000137	0.000146	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000137	0.000146	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000137	0.000146	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000135	0.000144	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	0.000131	0.00014	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	0.000131	0.00014	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	0.00013	0.000138	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000129	0.000138	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000129	0.000137	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000128	0.000136	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000127	0.000136	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000127	0.000135	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000127	0.000135	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000126	0.000135	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000126	0.000135	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000126	0.000134	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	0.000126	0.000134	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000125	0.000134	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000125	0.000134	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000125	0.000133	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000121	0.000129	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.00012	0.000128	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000119	0.000127	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000115	0.000123	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000115	0.000123	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000115	0.000122	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000115	0.000122	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000114	0.000121	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000114	0.000121	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000108	0.000116	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000108	0.000115	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000107	0.000114	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.87e-05	0.000105	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.83e-05	0.000105	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.77e-05	0.000104	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.74e-05	0.000104	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.74e-05	0.000104	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.71e-05	0.000104	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.68e-05	0.000103	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.65e-05	0.000103	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.59e-05	0.000102	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.24e-05	9.86e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.21e-05	9.83e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.14e-05	9.75e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.12e-05	9.73e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.11e-05	9.72e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.02e-05	9.63e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.96e-05	9.56e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.93e-05	9.53e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.84e-05	9.44e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.52e-05	9.09e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	8.49e-05	9.06e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.41e-05	8.97e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.29e-05	8.85e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.27e-05	8.82e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.19e-05	8.74e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.61e-05	8.13e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.59e-05	8.1e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.52e-05	8.02e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.46e-05	7.97e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.44e-05	7.94e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.37e-05	7.86e-05	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	6.31e-05	6.73e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.74e-05	6.12e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	5.72e-05	6.1e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.66e-05	6.04e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.29e-05	5.65e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.28e-05	5.63e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.22e-05	5.58e-05	CbGpPWpGaD
